Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7152406, 6 pages
https://doi.org/10.1155/2017/7152406
Research Article

Gastrointestinal Bleeding Is an Independent Risk Factor for Poor Prognosis in GIST Patients

1Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, China
2Department of General Surgery, The People’s Hospital of China Medical University, Shenyang, China

Correspondence should be addressed to Qi Dong; nc.ude.umc@iqgnod

Received 2 March 2017; Accepted 13 April 2017; Published 15 May 2017

Academic Editor: Toshimi Chiba

Copyright © 2017 Qi Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Nilsson, P. Bümming, and J. M. Meis-Kindblom, “Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden,” Cancer, vol. 103, no. 4, pp. 821–829, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Rammohan, J. Sathyanesan, K. Rajendran et al., “A gist of gastrointestinal stromal tumors: a review,” World Journal of Gastrointestinal Oncology, vol. 5, no. 6, pp. 102–112, 2012. View at Publisher · View at Google Scholar
  3. G. A. Watson, D. Kelly, M. Melland-Smith et al., “Get the GIST? An overview of gastrointestinal stromal tumours,” Irish Journal of Medical Science, vol. 185, no. 2, pp. 319–326, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. G. D. Demetri, M. M. Von, C. R. Antonescu et al., “NCCN task force report: update on the management of patients with gastrointestinal stromal tumors,” Journal of the National Comprehensive Cancer Network, vol. 2, 8, no. 4, pp. S1–S44, 2010. View at Publisher · View at Google Scholar
  5. C. D. M. Fletcher, J. J. Berman, C. Corless et al., “Diagnosis of gastrointestinal stromal tumors: a consensus approach,” Human Pathology, vol. 33, no. 5, pp. 459–465, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Joensuu, “Risk stratification of patients diagnosed with gastrointestinal stromal tumor,” Human Pathology, vol. 39, no. 10, pp. 1411–1419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Miettinen and J. Lasota, “Gastrointestinal stromal tumors: pathology and prognosis at different sites,” Seminars in Diagnostic Pathology, vol. 23, no. 2, pp. 70–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. P. Rubin, S. Singer, C. Tsao et al., “KIT activation is a ubiquitous feature of gastrointestinal stromal tumors,” Cancer Research, vol. 61, no. 22, pp. 8118–8121, 2001. View at Google Scholar · View at Scopus
  9. A. Kern, H. Görgens, D.-D. Dittert et al., “Mutational status of KIT and PDGFRA and expression of PDGFRA are not associated with prognosis after curative resection of primary Gastrointestinal Stromal Tumors (GISTs),” Journal of Surgical Oncology, vol. 104, no. 1, pp. 59–65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. G. Kindblom, H. E. Remotti, and F. Aldenborg, “Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal,” The American journal of Pathology, vol. 152, no. 5, pp. 1259–1269, 1998. View at Google Scholar · View at Scopus
  11. S. Hirota, K. Isozaki, Y. Moriyama et al., “Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors,” Science, vol. 279, no. 5350, pp. 577–580, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Miettinen, “Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis,” Archives of Pathology & Laboratory Medicine, vol. 130, no. 10, pp. 1466–1478, 2006. View at Google Scholar
  13. A. D. Uçar, E. Oymaci, E. B. Carti et al., “Characteristics of Emergency gastrointestinal stromal tumor (GIST),” Hepato-Gastroenterology, vol. 62, no. 139, pp. 635–640, 2015. View at Google Scholar · View at Scopus
  14. J. K. Trupiano, R. E. Stewart, C. Misick, H. D. Appelman, and J. R. Goldblum, “Gastric stromal tumors: a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors,” American Journal of Surgical Pathology, vol. 26, no. 6, pp. 705–714, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. B. K. P. Goh, P. K. H. Chow, W.-M. Yap et al., “Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified armed forces institute of pathology risk criteria,” Annals of Surgical Oncology, vol. 15, no. 8, pp. 2153–2163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Miettinen and J. Lasota, “Gastrointestinal stromal tumors,” Gastroenterology Clinics of North America, vol. 42, no. 2, pp. 399–415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. T. L. Frankel, A. E. Chang, and S. L. Wong, “Surgical options for localized and advanced gastrointestinal stromal tumors,” Journal of Surgical Oncology, vol. 104, no. 8, pp. 882–887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. R. P. DeMatteo, J. J. Lewis, D. Leung, S. S. Mudan, J. M. Woodruff, and M. F. Brennan, “Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival,” Annals of Surgery, vol. 231, no. 1, pp. 51–58, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. B. L. Eisenberg and I. Judson, “Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy,” Annals of Surgical Oncology, vol. 11, no. 5, pp. 465–475, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Joensuu, M. Eriksson, K. Sundby Hall et al., “Adjuvant imatinib for high-risk GI stromal tumor: analysis of a randomized trial,” Journal of Clinical Oncology, vol. 34, no. 3, pp. 244–250, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. S. J. Ford and A. Gronchi, “Indications for surgery in advanced/metastatic GIST,” European Journal of Cancer, vol. 63, pp. 154–167, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. P. S. Sepe and W. R. Brugge, “A guide for the diagnosis and management of gastrointestinal stromal cell tumors,” Nature Reviews Gastroenterology & Hepatology, vol. 6, no. 6, pp. 363–371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Lv, Z. Li, X. Tian et al., “SKP2 high expression, KIT Exon 11 deletions, and gastrointestinal bleeding as predictors of poor prognosis in primary gastrointestinal stromal tumors,” PLoS ONE, vol. 8, no. 5, Article ID e62951, 2013. View at Publisher · View at Google Scholar · View at Scopus